Hongliang Yao
4PUBLICATIONS
0CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (4)
Sort by Publication Date:
|Mar 07, 2025
Retraction Note: The miR-30a-5p/CLCF1 axis regulates sorafenib resistance and aerobic glycolysis in hepatocellular carcinoma.Zhongqiang Zhang, Xiao Tan, Jing Luo
|Mar 29, 2023
Retraction Note: Inhibition of EZH2 enhances the therapeutic effect of 5-FU via PUMA upregulation in colorectal cancer.Xiao Tan, Zhongqiang Zhang, Ping Liu
|Dec 14, 2020
Inhibition of EZH2 enhances the therapeutic effect of 5-FU via PUMA upregulation in colorectal cancer.Xiao Tan, Zhongqiang Zhang, Ping Liu
|Oct 24, 2020
The miR-30a-5p/CLCF1 axis regulates sorafenib resistance and aerobic glycolysis in hepatocellular carcinoma.Zhongqiang Zhang, Xiao Tan, Jing Luo
Pageof 1
